BioStabilization Systems (BoSS)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Contract Value
Not provided
Codes & Classification
Solicitation Number
ARPA-H-SOL-26-136
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN13
Additional Details
Documents5
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a solicitation for the BioStabilization Systems (BoSS) program (Procurement Identifier: ARPA-H-SOL-26-136). This initiative represents a significant federal investment in transforming the stabilization, manufacturing, and distribution of live cell-based therapies, with the overarching goal of overcoming the current reliance on ultra-cold storage conditions for advanced cell and gene therapies (CGTs).
Purpose and Scope:
The BoSS program is designed to address a critical bottleneck in the delivery of CGTs: the need for ultra-cold storage and transport (ranging from -80°C to -196°C). By developing a scalable bioprocessing system capable of producing thermally stable cells, BoSS aims to eliminate the cold chain requirement, thereby enabling more efficient, resilient, and accessible manufacturing and distribution of biologics. The anticipated outcomes extend beyond CGTs, with potential impacts on bio-surveillance, regenerative medicine, large-scale genetic testing, blood product supply, wound repair, and broader access to existing biotherapeutics.
Key Requirements and Deliverables:
Contractors are expected to propose innovative solutions that directly address the stabilization of live cell-based therapies without cold storage. The program seeks both Performers (entities developing and demonstrating the core technology) and Independent Verification & Validation (IV&V) partners (entities responsible for independent assessment of proposed solutions). Submissions must adhere to the requirements outlined in the BoSS Innovative Solutions Opening (ISO), including detailed cost proposal narratives and spreadsheets, as specified in the most recent amendments.
Recent amendments to the solicitation have clarified and updated several aspects, including:
- Extension of the Solution Pitch deadline for IV&V proposers to May 21, 2026.
- Removal of references to TA1/TA2 in cost proposal documents.
- Clarification of out-of-scope approaches, capability requirements, allowable IV&V partner entity types, and reporting requirements.
- Updates to terminology in proposal attachments (e.g., "lead organization" changed to "lead member").
Interested parties must use the latest versions of all attachments, as indicated in the amendments, and carefully review the ISO for all changes.
Submission Details:
- Solution Summaries for Performers are due by February 19, 2026, at 5:00 PM ET.
- Solution Summaries for IV&V partners are due by April 17, 2026, at 5:00 PM ET.
- All submissions must be made via the designated Solution Summary Submission Site: https://solutions.arpa-h.gov/Submit-Solution/
- The opportunity remains active, and interested contractors are encouraged to monitor the solicitation for updates.
Contracting Entity and Classification:
- Contracting Entity: Advanced Research Projects Agency for Health (ARPA-H), Federal Office
- Department: Health and Human Services, Department of
- Agency: National Institutes of Health
- Place of Performance: Washington, District of Columbia, United States
- NAICS Code: 541715 (Research and Development in the Physical, Engineering, and Life Sciences, except Nanotechnology and Biotechnology)
- Product Service Code: AN13
Procurement Type and Special Considerations:
This is a federal solicitation for innovative research and development solutions. The notice does not specify set-aside requirements or special socioeconomic considerations. Contractors should review the ISO and amendments for any eligibility criteria or partnership requirements, particularly for IV&V roles.
Contact and Additional Information:
- Primary contact information is provided in the description section of the solicitation.
- For more details on the BoSS program, visit: https://arpa-h.gov/explore-funding/programs/boss
- For information on Proposer’s Day and registration, refer to Special Notice ARPA-H-SN-26-137.
- The full solicitation and all amendments are available on SAM.gov (Opportunity ID: 386dd9dd3af249ee802bdba70106d610).
Summary:
The BoSS program represents a transformative opportunity for organizations specializing in bioprocessing, cell therapy, and advanced biologics manufacturing. Contractors with capabilities in developing scalable, thermally stable cell-based systems, as well as those with expertise in independent verification and validation, are encouraged to review the solicitation in detail and consider submitting a Solution Summary by the relevant deadlines. This initiative is poised to redefine the logistics and accessibility of advanced therapies, with broad implications for the future of healthcare and biotechnology.